class action lawsuit

Schall Law Firm launches securities fraud class action against Varonis Systems for allegedly making false statements about SaaS customer conversion and revenue growth during 2025.

Agilon Health faces securities class action lawsuit alleging materially false 2026 financial guidance and misleading statements about risk mitigation. Investors from February-August 2025 may participate.

Schall Law Firm recruits lead plaintiffs for MCTA securities fraud class action lawsuit stemming from alleged undisclosed promotion scheme and SEC trading suspension.

Class action lawsuit filed against Klarna alleging IPO securities fraud over undisclosed financial risks and misleading statements about loss reserves.

BlackRock TCP Capital faces securities fraud lawsuit alleging false statements about investment valuations and overstated net asset value. Investors have until April 6, 2026 to join.

Law firm seeks lead plaintiffs for MCTA class action lawsuit over alleged undisclosed stock promotion scheme and social media fraud. Deadline: February 17, 2026.

Klarna faces securities lawsuit alleging it concealed loss reserve increases in its September 2025 IPO. Investors have until February 20 to join the class action.

F5 faces class action lawsuit over undisclosed BIG-IP security breach. Stock plunged 10.9% after October disclosure; shareholders sought for litigation by February 17 deadline.

Rosen Law Firm filed a securities class action against Agilon Health for allegedly making false 2025 guidance statements. Investors harmed between February-August 2025 can participate; deadline March 2, 2026.

GSI Technology faces securities investigation for allegedly making false claims about chip capabilities. Stock dropped 14.2% after reports showed products didn't perform as advertised.

Class action lawsuit filed against Fermi Inc. alleging material misrepresentations in October 2025 IPO regarding Project Matador demand and financial viability disclosures.

Class action lawsuit filed against Ardent Health for allegedly overstating Q3 2025 revenue and inflating full-year EBITDA guidance by $57.5 million due to accounting system failures.

Ultragenyx Pharmaceutical faces class action lawsuit for allegedly making false statements about setrusumab drug efficacy and safety, affecting investors who bought securities between August 2023 and December 2025.

F5 faces class action lawsuit alleging it misrepresented security capabilities and failed to disclose a major product breach affecting investors between October 2024-2025.

Bath & Body Works faces a class action lawsuit for allegedly making false statements about its growth strategy's effectiveness and failing to disclose poor results to investors.

Law firm sues Oracle for allegedly misleading investors about AI spending's near-term revenue potential. Stock fell 11% after earnings missed expectations.

Fermi Inc. faces securities fraud lawsuit over Project Matador disclosures, alleging misrepresentation of tenant commitments. Stock fell 33% after primary tenant withdrew funding in December 2025.

Ardent Health faces class action lawsuit over misrepresented revenue recognition practices. Company disclosed $43M revenue reduction and 33% stock decline following accounting restatement allegations.

Hub Group to restate 2025 financial results due to accounting errors in transportation costs and payables, causing 24% stock decline and triggering potential shareholder litigation.

Kyndryl faces securities lawsuit after SEC discovers accounting irregularities. Stock plunges 52% as CFO and General Counsel resign.